May 31, 2026 by Geoffrey SeilerBetter AI Inference Stock to Own: Nvidia or Cerebras?Both stocks have a big inference opportunity ahead.
May 31, 2026 by Reuben Gregg BrewerIs Pfizer Stock a "Value Trap" or a Generational Opportunity?Pfizer is an over-100-year-old drug company going through a rough patch, which has happened before.
May 31, 2026 by James Brumley3 Reasons to Buy Cameco Stock Like There's No TomorrowThe stock's taking a breather after a recent rally, but the company's bright future is likely to manifest sooner rather than later.
May 31, 2026 by Geoffrey SeilerBetter AI Inference Stock to Own: Nvidia or Cerebras?Both stocks have a big inference opportunity ahead.
May 31, 2026 by Maurie BackmanWant to Grow Your Portfolio Without Any Effort? Buy This ETF and Hold It Till You Retire.It's a super easy way to invest over the long haul.
May 31, 2026 by Cory RenauerKalVista's (KALV) Chief Development Officer Sells 33,800 Shares for $905,000This clinical-stage biotech focused on rare diseases reported a notable insider sale amid a year of strong stock performance.
May 31, 2026 by Kailey Hagen, CFPYour Social Security Checks Could Get a Huge Boost in 2027. How That Could Affect You if You Live in 1 of the 8 States That Taxes Benefits.Some of your COLA might wind up in your state's coffers instead of in your pocket.
May 31, 2026 by Matthew BenjaminDRAM Memory Boom: Why Micron Stock Could Still DoubleMicron's share price doubled in 48 days.
May 31, 2026 by Dominic Basulto1 Top Cryptocurrency to Buy Before It Soars 1,600%, According to Cathie Wood of Ark InvestBitcoin could soar to a price of $1.25 million within the next 5 years.
May 31, 2026 by Reuben Gregg BrewerIs Pfizer Stock a "Value Trap" or a Generational Opportunity?Pfizer is an over-100-year-old drug company going through a rough patch, which has happened before.
May 31, 2026 by James Brumley3 Reasons to Buy Cameco Stock Like There's No TomorrowThe stock's taking a breather after a recent rally, but the company's bright future is likely to manifest sooner rather than later.
May 31, 2026 by Cory RenauerA Progyny (PGNY) Insider Sold 5,500 Shares for $137,000Progyny delivers fertility benefits to major employers; a key insider recently trimmed their stake, according to SEC filings.
May 31, 2026 by Matt DiLallo3 Monster Dividend Stocks to Buy in June (1 Yields an Eye-Popping 11.2%!)These ultra-high-yielding dividend stocks have done a solid job delivering sustainable income streams.
May 31, 2026 by Beth McKennaInterested in Humanoid Robot Stocks? You Might Consider Buying This Humanoid Robotics ETFThis humanoid robotics ETF (KOID) has been performing wonderfully, though it's only been in existence for about a year.
May 31, 2026 by Jennifer SaibilGreg Abel Just Sold Both Visa and Mastercard Stock but Kept This Top Buffett FavoriteBuffett said he'd never sell it, and Abel is keeping it on.
May 31, 2026 by Neil Patel3 Things Long-Term Investors Should Do As June ArrivesThe start of a new month provides the perfect opportunity to take a fresh look at your portfolio.
May 31, 2026 by Maurie BackmanI Used to Think a 401(k) Was the Best Retirement Savings Tool. But Here Are 4 Issues to Know About.While 401(k)s are convenient, they're far from perfect.
May 31, 2026 by Cory RenauerXometry's (XMTR) CEO Recently Sold 50K Shares. Should You Follow?This digital manufacturing platform, serving diverse industries, reported a notable insider sale amid strong one-year stock performance.
May 31, 2026 by Cory RenauerPeleton's (PTON) Chief Commercial Officer Sold All Their Shares for $584,000Peloton, a leader in connected fitness and digital subscriptions, reported a notable insider sale amid ongoing market challenges.
May 31, 2026 by Bryan WhiteBorgWarner's Data Center Deal Has It Shifting Gears From Drivetrains to Large Language ModelsThe legacy business is funding a shift to electric vehicles (EVs) and industrial power generation.
May 31, 2026 by Cory RenauerAn Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 MillionThis clinical-stage biotech focused on antibody therapies for immunological disorders reported a notable insider sale in its latest filing.
May 31, 2026 by Cory RenauerFranklin Electric's (FELE) President Sold 1,900 Shares. Should You Follow His Lead?This global pumping systems provider operates across key infrastructure markets; a recent insider sale highlights evolving ownership trends.
May 31, 2026 by Cory RenauerVelan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 MillionMineralys Therapeutics develops novel therapies for resistant hypertension, with its lead candidate advancing through clinical trials.
